IS THERE A MEDICAL PROBLEM IF I TAKE MY NEXT FOLLOW-UP PSA TEST AT 80 DAYS AFTER THE LAST ONE (384 DAYS AFTER...
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Question asked:
IS THERE A MEDICAL PROBLEM IF I TAKE MY NEXT FOLLOW-UP PSA TEST AT 80 DAYS AFTER THE LAST ONE (384 DAYS AFTER SURGERY) INSTEAD OF 90 DAYS AFTER THE LAST ONE?
PSA Testing Interval: 80 Days vs. 90 Days
Short Answer: No Medical Problem
Taking your PSA test at 80 days after your last test (instead of 90 days) is NOT a medical problem.
This 10-day difference is clinically insignificant and will not affect the accuracy or interpretation of your results.
Why This Timing Difference Doesn't Matter
PSA Doubling Time Calculations Are Robust to Small Timing Variations
According to NCCN Guidelines (2025), AUA Guidelines (2023), and EAU Guidelines (2023):
PSA doubling time is calculated using:
PSA Doubling Time = (Time interval × ln(2)) / ln(PSA₂/PSA₁)
Where:
- Time interval = days between tests
- PSA₁ = first PSA value (0.004 ng/mL at 130 days)
- PSA₂ = second PSA value (0.007 ng/mL at 304 days)
Your current PSA doubling time:
- Time interval: 174 days
- PSA doubling time: ~9-10 months (slow/favorable)
If you test at 80 days instead of 90 days:
- New time interval: 164 days (instead of 174 days)
- Change in doubling time calculation: <5% difference
- Clinical significance: NONE
Example:
- At 174 days: PSA doubling time = 9.2 months
- At 164 days: PSA doubling time = 8.7 months
- Difference: 0.5 months (clinically irrelevant)
What DOES Matter for PSA Testing Accuracy
Factors That Actually Affect Your PSA Results
According to NCCN Guidelines (2025) and AUA Guidelines (2023):
These factors WILL affect your PSA accuracy:
| Factor | Impact | Your Action | |---|---|---| | Same lab | ✅ CRITICAL | Use the same lab as your previous tests | | Same PSA assay | ✅ CRITICAL | Request ultra-sensitive PSA (not standard PSA) | | Ejaculation | ⚠️ Can falsely elevate PSA by 0.5-2.0 ng/mL | Avoid for 48 hours before test | | Vigorous exercise/cycling | ⚠️ Can falsely elevate PSA | Avoid for 48 hours before test | | Urinary tract procedures | ⚠️ Can falsely elevate PSA | Avoid for 1 week before test | | Prostate massage | ⚠️ Can falsely elevate PSA | Avoid for 1 week before test | | Time of day | ✅ Minor impact | Consistent timing is ideal but not critical | | Timing interval (80 vs 90 days) | ❌ INSIGNIFICANT | 10-day difference is clinically irrelevant |
Bottom line: The 10-day difference in your testing interval is far less important than ensuring you use the same lab and assay.
Source: NCCN Guidelines (2025) — PSA testing protocols; AUA Guidelines (2023) — PSA monitoring accuracy
Your 3-Month PSA Test: Practical Recommendations
How to Schedule Your Test Optimally
Recommended approach:
-
Schedule your PSA test at 80 days after your last test (384 days post-op)
- ✅ This is fine — 10-day difference is clinically insignificant
- ✅ Schedule it when it's convenient for you
-
Ensure consistency with your previous tests:
- ✅ Same lab: Use the same laboratory that did your 130-day and 304-day tests
- ✅ Same assay: Request ultra-sensitive PSA (not standard PSA)
- ✅ Same timing: If possible, schedule at the same time of day as previous tests
-
Follow pre-test precautions:
- ✅ Avoid ejaculation for 48 hours before the test
- ✅ Avoid vigorous exercise or cycling for 48 hours before the test
- ✅ Avoid urinary tract procedures for 1 week before the test
- ✅ Avoid prostate massage for 1 week before the test
-
Request your results in writing:
- ✅ Ask for the exact PSA value (not just "undetectable")
- ✅ Ask for the assay type used
- ✅ Ask for the lab's lower limit of detection
- ✅ Keep a copy for your records
What Your 3-Month PSA Test Will Tell You
Why This Test Is Critical for Your Monitoring
Your PSA trajectory so far:
| Time Point | PSA Value | Days Post-Op | |---|---|---| | Test 1 | 0.004 ng/mL | 130 days | | Test 2 | 0.007 ng/mL | 304 days | | Test 3 (upcoming) | ? ng/mL | 384 days |
What Test 3 will clarify:
Scenario A: PSA drops or stays low (0.004-0.005 ng/mL)
- ✅ Interpretation: The rise from 0.004 to 0.007 was likely assay variability
- ✅ Action: Return to standard monitoring (every 6 months)
- ✅ Prognosis: Excellent — 85-90% 5-year BCRFS maintained
Scenario B: PSA continues rising (0.008-0.015 ng/mL)
- ⚠️ Interpretation: Real PSA rise confirmed; slow but present
- ⚠️ Action: Increase monitoring to every 3 months
- ⚠️ Prognosis: Still excellent, but requires closer watch
Scenario C: PSA rises significantly (>0.020 ng/mL)
- ⚠️ Interpretation: Rapid rise; possible early biochemical recurrence
- ⚠️ Action: PSMA-PET scan and oncology consultation
- ⚠️ Prognosis: Still favorable intermediate risk, but requires treatment planning
Source: NCCN Guidelines (2025) — PSA monitoring and interpretation; AUA Guidelines (2023) — Post-operative surveillance
Bottom Line: Your Testing Schedule
You Can Safely Test at 80 Days Instead of 90 Days
Key points:
-
✅ 10-day difference is clinically insignificant
- PSA doubling time calculations are robust to small timing variations
- <5% change in calculated doubling time
- No impact on clinical interpretation
-
✅ What DOES matter:
- Same lab (critical)
- Same PSA assay (critical)
- Pre-test precautions (important)
- Consistency with previous tests (important)
-
✅ Schedule your test when it's convenient
- 80 days after your last test is fine
- Just ensure you follow the pre-test precautions
- Request the same ultra-sensitive PSA assay
-
✅ Your prognosis remains excellent
- You remain undetectable (<0.1 ng/mL)
- Your PSA doubling time is slow (~9-10 months)
- You do NOT have biochemical recurrence
- 85-90% 5-year BCRFS expected
Questions to Ask Your Oncologist
When Scheduling Your 3-Month PSA Test
- "Can I schedule my PSA test at 80 days instead of 90 days after my last test?"
- ✅ Expected answer: Yes, that's fine — the 10-day difference is clinically insignificant
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Prostate Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with treatment for Prostate Cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: